Molecular Determinants of CGS21680 Binding to the Human Adenosine A2A Receptor

Molecular Pharmacology
Guillaume LebonChristopher G Tate

Abstract

The adenosine A2A receptor (A(2A)R) plays a key role in transmembrane signaling mediated by the endogenous agonist adenosine. Here, we describe the crystal structure of human A2AR thermostabilized in an active-like conformation bound to the selective agonist 2-[p-(2-carboxyethyl)phenylethyl-amino]-5'-N-ethylcarboxamido adenosine (CGS21680) at a resolution of 2.6 Å. Comparison of A(2A)R structures bound to either CGS21680, 5'-N-ethylcarboxamido adenosine (NECA), UK432097 [6-(2,2-diphenylethylamino)-9-[(2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxy-tetrahydrofuran-2-yl]-N-[2-[[1-(2-pyridyl)-4-piperidyl]carbamoylamino]ethyl]purine-2-carboxamide], or adenosine shows that the adenosine moiety of the ligands binds to the receptor in an identical fashion. However, an extension in CGS21680 compared with adenosine, the (2-carboxyethyl)phenylethylamino group, binds in an extended vestibule formed from transmembrane regions 2 and 7 (TM2 and TM7) and extracellular loops 2 and 3 (EL2 and EL3). The (2-carboxyethyl)phenylethylamino group makes van der Waals contacts with side chains of amino acid residues Glu169(EL2), His264(EL3), Leu267(7.32), and Ile274(7.39), and the amine group forms a hydrogen bond with the side chain of Ser67(2.65). Of ...Continue Reading

References

Dec 1, 1973·Analytical Biochemistry·W Schaffner, C Weissmann
Oct 1, 1994·Journal of Neurochemistry·R Askalan, P J Richardson
May 1, 1997·Acta Crystallographica. Section D, Biological Crystallography·G N MurshudovE J Dodson
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·Paul Emsley, Kevin Cowtan
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·Liz PottertonMartin Noble
Dec 22, 2005·Acta Crystallographica. Section D, Biological Crystallography·Andrew G W Leslie
Dec 22, 2005·Acta Crystallographica. Section D, Biological Crystallography·Philip Evans
Feb 24, 2006·Journal of Molecular Biology·Vadim CherezovMartin Caffrey
Mar 7, 2006·Nature Reviews. Drug Discovery·Kenneth A Jacobson, Zhan-Guo Gao
Jun 24, 2006·Journal of Molecular Graphics & Modelling·Soo-Kyung KimKenneth A Jacobson
Apr 25, 2009·Nature Protocols·Martin Caffrey, Vadim Cherezov
Aug 1, 2007·Journal of Applied Crystallography·Airlie J McCoyRandy J Read
Aug 18, 2009·Current Opinion in Structural Biology·Christopher G Tate, Gebhard F X Schertler
Jan 14, 2011·Nature·Søren G F RasmussenBrian K Kobilka
Mar 12, 2011·Science·Fei XuRaymond C Stevens
Mar 19, 2011·Trends in Pharmacological Sciences·Brian K Kobilka
Apr 20, 2011·Journal of Molecular Biology·Guillaume LebonChristopher G Tate
May 5, 2011·Proceedings of the National Academy of Sciences of the United States of America·Rouslan MoukhametzianovGebhard F X Schertler
May 19, 2011·Advances in Pharmacology·J Robert LaneAdriaan P Ijzerman
Jul 21, 2011·Nature·Søren G F RasmussenBrian K Kobilka
Aug 26, 2011·British Journal of Pharmacology·M WheatleyJ Barwell
Jan 10, 2012·Journal of Medicinal Chemistry·Miles CongreveFiona H Marshall
Jan 19, 2012·Journal of Medicinal Chemistry·Christopher J LangmeadMalcolm Weir
Apr 7, 2012·Current Opinion in Structural Biology·Guillaume LebonChristopher G Tate
Jul 13, 2012·Trends in Biochemical Sciences·Christopher G Tate
Jul 17, 2012·Science·Wei LiuRaymond C Stevens
Feb 15, 2013·Nature·A J VenkatakrishnanM Madan Babu
Feb 23, 2013·Molecular Pharmacology·Kirstie A BennettChristopher J Langmead
Nov 22, 2013·Nature·Andrew C KruseBrian K Kobilka

❮ Previous
Next ❯

Citations

Jun 24, 2015·Proceedings of the National Academy of Sciences of the United States of America·Jordi BonaventuraVicent Casadó
Dec 22, 2015·Neuropharmacology·Kenneth A Jacobson, Christa E Müller
Mar 13, 2016·Purinergic Signalling·Elisabetta De FilippoChrista E Müller
Jun 24, 2016·Journal of Computer-aided Molecular Design·Andrew Anighoro, Jürgen Bajorath
Jun 23, 2016·Chemical Reviews·Ali JazayeriFiona H Marshall
Aug 21, 2016·FEBS Letters·Nicole S SchonenbachMichelle A O'Malley
Feb 25, 2017·Cell·Alisa GlukhovaArthur Christopoulos
Mar 14, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Antonella Ciancetta, Kenneth A Jacobson
May 16, 2017·Platelets·Eduardo FuentesChrista E Müller
Jul 7, 2017·Medicinal Research Reviews·Kenneth A JacobsonStefania Gessi
Jan 10, 2018·Frontiers in Pharmacology·Byron Carpenter, Guillaume Lebon
Jul 28, 2016·Nature·Byron CarpenterChristopher G Tate
Jul 4, 2018·Acta Crystallographica. Section D, Structural Biology·Ronald E Stenkamp
Nov 23, 2018·Proceedings of the National Academy of Sciences of the United States of America·Lukas SušacKurt Wüthrich
Mar 26, 2019·Journal of Leukocyte Biology·Kai XuRebecca D Levit
May 28, 2019·Journal of Computer-aided Molecular Design·Lee H WinkAbby L Parrill
Mar 6, 2019·Current Pharmaceutical Design·Nizar A Al-Shar'i, Qosay A Al-Balas
Oct 11, 2019·Pharmaceuticals·Diego Dal BenRosaria Volpini
Feb 9, 2017·Proceedings of the National Academy of Sciences of the United States of America·Bingfa SunBrian K Kobilka
Oct 20, 2018·Expert Opinion on Drug Discovery·Miles CongreveMichelle L Lamb
Nov 24, 2019·Journal of Computer-aided Molecular Design·Antonella CiancettaKenneth A Jacobson
Jun 24, 2017·Chemical Biology & Drug Design·Alisha D CalimanJames A McCammon
Mar 3, 2018·Frontiers in Pharmacology·Estefanía MorenoVicent Casadó
Jan 1, 2017·AIMS Biophysics·Samantha B GacasanAbby L Parrill
Jul 25, 2019·Current Pharmaceutical Design·Omar H A Al-AttraqchiNoor H A Al-Attraqchi
May 13, 2018·Purinergic Signalling·Sonja HinzChrista E Müller
Nov 7, 2019·International Journal of Molecular Sciences·Nina Wolska, Marcin Rozalski
Apr 14, 2016·Biochemical Society Transactions·Verònica Casadó-AngueraVicent Casadó
Feb 13, 2021·Frontiers in Pharmacology·P BoknikU Gergs

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.